v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash flows from operating activities:    
Net loss $ (6,136,349) $ (7,832,942)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 959,207 552,004
Amortization of loan discount and fees 1,412,425 1,093,583
Loss on extinguishment of debt 689,100  
Stock-based compensation 105,594 139,093
Shares issued for services 499,338  
Change in credits due customers 109,298 (9,067)
Change in fair value of warrant liability   (5,970)
Change in fair value of derivative liability   682,103
Change in fair value of contingent consideration   1,200,321
Changes in operating assets and liabilities:    
Accounts receivable, net 282,947 (49,554)
Factored receivables (77,776) 294,439
Inventory 299,188 262,753
Prepaid expenses and other current assets (218,286) (126,369)
Accounts payable (416,093) 1,972,441
Accrued expenses and other liabilities 464,855 669,514
Deferred revenue 115,292 71,707
Accrued interest 218,740 450,788
Net cash used in operating activities (1,692,520) (635,156)
Cash flows from investing activities:    
Purchase of property, equipment and software   (5,576)
Deposits 87,379  
Net cash provided by (used in) investing activities 87,379 (5,576)
Cash flows from financing activities:    
Proceeds (repayments) from related party advances (104,170) (11,105)
Advances (repayments) from factor 217,625 (179,126)
Issuance of loans and note payable 3,542,199 868,582
Repayment of convertible notes and loan payable (5,677,621)  
Issuance of common stock pursuant to private placement 5,000,003  
Offering costs (686,927)  
Net cash provided by financing activities 2,291,109 678,351
Net change in cash and cash equivalents 685,968 37,619
Cash and cash equivalents at beginning of period 1,283,282 528,394
Cash and cash equivalents at end of period 1,969,250 566,013
Supplemental disclosure of cash flow information:    
Cash paid for interest 60,465  
Supplemental disclosure of non-cash investing and financing activities:    
Conversion of notes into common stock   1,201,582
Right of use asset $ 467,738 $ 250,244